Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|December 18, 2007
Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitorsShihua Xu, Brian M McKeever, Douglas Wisniewski, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 6, 2004
Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4Guochang Yang, Angela Haczku, Hang Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2004
The membrane organization of leukotriene synthesisAsim K Mandal, Jesse Skoch, Brian J Bacskai, et al.
European Journal of Pharmacology|May 8, 2010
Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammationKarin J Stebbins, Alex R Broadhead, Lucia D Correa, et al.
International Archives of Allergy and Immunology|November 2, 2011
DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virusKarin J Stebbins, Alexander R Broadhead, Alla Musiyenko, et al.
Pharmacogenetics|September 30, 2003
A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da CunhaMiles D Thompson, Karin Storm van's Gravesande, Helen Galczenski, et al.
American Journal of Respiratory Cell and Molecular Biology|September 8, 2025
Extracellular Matrix and Fibroblast Activation in LymphangioleiomyomatosisAlexander R Mukhitov, Jilly F Evans, Tiegang Han, et al.
Science (New York, N.Y.)|June 30, 2007
Crystal structure of inhibitor-bound human 5-lipoxygenase-activating proteinAndrew D Ferguson, Brian M McKeever, Shihua Xu, et al.
American Journal of Respiratory Cell and Molecular Biology|November 12, 2024
The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in LymphangioleiomyomatosisJilly F Evans, Owen A Ledwell, Yan Tang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2010
5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)-A potent FLAP inhibitor suitable for topical administrationNicholas Stock, Christopher Baccei, Gretchen Bain, et al.
Pageof 5